Corporate Governance25 Jun 2026, 03:56 pm
Medicamen Biotech Ltd Closes Trading Window from July 1
AI Summary
Medicamen Biotech Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. The window will be shut from July 01, 2026, and will reopen 48 hours after the declaration of the un-audited financial results for the quarter ended June 30, 2026. This measure is in compliance with the company's code of conduct for regulating trading by insiders. All concerned individuals have been advised against trading in the company's securities during this period. The date for the board meeting to approve these financial results will be communicated separately.
Key Highlights
- Trading window closure effective July 01, 2026.
- Closure is for designated persons and connected individuals.
- Window reopens 48 hours post Q1 FY27 results announcement.
- Purpose is to prevent insider trading during results declaration.
Price Impact
More from MEDICAMEQ